Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
Combined mpMRI and PSMA PET/CT for csPCa diagnosis are a cost-effective strategy in terms of health utility over the conventional approach for diagnosing csPCa in men with raised PSA, potentially reducing the need for invasive diagnostic procedures.
Authors
- A. K. Y. Lee
- Kit Mun Chow
- Jingqiu Li (ORCID: https://orcid.org/0000-0002-9789-0729)
- W. J. J. Chen
- K. Chen
- Joshua Yi Min Tung (ORCID: https://orcid.org/0000-0003-4991-9790)
- Julene Hui Wun Ong (ORCID: https://orcid.org/0009-0001-0809-6786)
- E H C Teo
- Wwm Lam
- Christopher Wai Sam Cheng (ORCID: https://orcid.org/0000-0002-5274-3004)
- Henry Sun Sien Ho
- Xinyan Yang
- John Shyi‐Peng Yuen
- Yan Mee Law
- Sue Ping Thang
- Yu Guang Tan
- Kae Jack Tay
- Timothy Siliang Lu
- Rachel Shu‐En Lau
Institutions
- Singapore General Hospital (SG)
- National University Hospital (SG)
Publication Details
- Journal
- BJUI Compass
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/bco2.70172
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Duke-NUS Medical School
- National University of Singapore